A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Giant Cell Arteritis
Status:
Terminated
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy (effectiveness) of
Infliximab (Remicade) in patients with Giant Cell Arteritis. Infliximab (Remicade) targets
specific proteins in the body's immune system to help control the development of inflammation
to help reduce painful disease.